MoneyWorks4Me

Ajanta Pharma - Quaterly Results

02 May 2024 Evaluate
The company witnessed a 9.10% growth in the revenue at Rs. 9260.70 millions for the quarter ended March 2024 as compared to Rs. 8488.60 millions during the year-ago period.Good  Net Profit growth of 38.80% reported above the corresponding previous quarter figure of Rs. 1172.10 millions to Rs. 1626.90 millioins.The company reported a good operating profit of 2608.30 millions compared to 1812.80 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 9260.70 8488.60 9.10 39711.20 34112.70 16.41 39711.20 34112.70 16.41
Other Income 336.80 367.50 -8.35 1164.80 1327.50 -12.26 1164.80 1327.50 -12.26
PBIDT 2608.30 1812.80 43.88 12359.10 8320.30 48.54 12359.10 8320.30 48.54
Interest 14.20 12.10 17.36 68.00 52.30 30.02 68.00 52.30 30.02
PBDT 2594.10 1800.70 44.06 12291.10 8268.00 48.66 12291.10 8268.00 48.66
Depreciation 334.70 321.10 4.24 1321.60 1269.50 4.10 1321.60 1269.50 4.10
PBT 2259.40 1479.60 52.70 10969.50 6998.50 56.74 10969.50 6998.50 56.74
TAX 632.50 307.50 105.69 2897.10 1411.30 105.28 2897.10 1411.30 105.28
Deferred Tax 34.20 -84.50 -140.47 121.30 -29.30 -513.99 121.30 -29.30 -513.99
PAT 1626.90 1172.10 38.80 8072.40 5587.20 44.48 8072.40 5587.20 44.48
Equity 252.70 252.70 0.00 252.70 252.70 0.00 252.70 252.70 0.00
PBIDTM(%) 28.17 21.36 31.89 31.12 24.39 27.60 31.12 24.39 27.60
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..